Dolutegravir/TIVICAY is an Integrase Inhibitor that was approved in 2013. It is extremely well tolerated with very few known side effects. This medicine may change the results of liver function tests, but not necessarily actual liver function. Take once or twice a day with or without food. Avoid taking antacids, laxatives, and vitamins 6 hours before or 2 hours after taking. Dolutegravir is one of three components in the triple combination pill TRIUMEQ.
DO NOT take with the heart medication dofetilide.